The USC Jorge H. Mestman Endocrine and Pregnancy Symposium

Saturday, February 19, 2022, 7:45 AM - 1:15 PM, Virtual Conference


AMA PRA Category 1 Credits™ (4.75 hours), Non-Physician Attendance (4.75 hours)

This program was created and named in honor of Dr. Jorge H. Mestman, a dedicated physician, teacher and mentor to many for more than 40 years and going. His significant contributions to the field of endocrine in pregnancy continue to shape how we practice today. His philosophy of excellence in patient care and his values of integrity and collaboration are the foundations of this symposium. 

The goal of this program is to provide a comprehensive and current update in the management of endocrine disease as related to pregnancy, a unique and challenging time in patients' lives. Management of endocrine disease during pregnancy has become increasingly multifaceted as new evidence-based management strategies emerge. 

This inaugural program presents standards of practice as well as forward-looking perspectives representing the most current state of endocrine medicine. The talks focus on recent advancement and recommendations in the management of gestational diabetes, the long-term impact of metabolic disease for mother and child, the role of advanced technologies including continuous glucose monitors, and fetal ultrasound, unique considerations in pregnancy for patients with PCOS, pituitary disease, and Graves' Hyperthyroidism, and the current debate of universal thyroid screening. 

Presentations combining evidence-based medicine and clinical experience, challenging cases, and panel discussions from audience questions, help inform practice decisions in an era of complex clinical challenges.

1. Counsel patients diagnosed with gestational diabetes in regards to screening, medical management, lifestyle changes, pregnancy and postpartum implications to mother and child, and available technologies.
2. Conduct preconception counseling with patients with Graves' Hyperthyroidism and develop an approach to medication choice and titration during pregnancy.
3. Examine the unique challenges for caring for patients with PCOS and pituitary disease to best optimize care prior to, during and after pregnancy.
4. Assess the role of new technologies such as continuous glucose monitors and ultrasound in the management of patients with endocrine conditions in pregnancy.

The Keck School of Medicine of the University of Southern California designates this Live Activity activity for a maximum of 4.75 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Cancellation Policy

Cancellations must be received by the USC Office of CME by email only by February 14, 2022, 12:00 pm PST for a refund. In support of health care professionals' need for flexibility during COVID-19, cancellation fees are waived for a full refund. In the event of course cancellation by conference organizers, all registration fees will be fully refunded.


Accessibility Statement
 
Keck School of Medicine Healthcare System is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008. If you have needs that require special accommodations, including dietary concerns, please contact the USC Office of CME at [email protected].

The registration form for this activity is currently unavailable.

The Keck School of Medicine Healthcare System School of Medicine adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

Keck School of Medicine Continuing Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Saturday, February 19, 2022